Design of a randomised controlled trial of the effects of empagliflozin on myocardial perfusion, function and metabolism in type 2 diabetes patients at high cardiovascular risk (the SIMPLE trial).

Mikkel JürgensMorten SchouPhilip HasbakAndreas KjærEmil WolskBo ZerahnMikkel WibergNiels Høgh BrandtPeter Haulund GædePeter RossingJens FaberSilvio InzucchiFinn GustafssonCaroline Michaela Kistorp

Published in: BMJ open (2019)

NCT03151343.

Keyphrases

type diabetes
phase iii
study protocol
clinical trial
phase ii
glycemic control
cardiovascular disease
insulin resistance
randomized controlled trial
weight loss
placebo controlled